Given that TRIB3 is highly expressed in BC tissues (Figure 2A), supports cancer stemness, and promotes tumor progression, inhibiting TRIB3 is suggested as a promising therapeutic strategy for BC (Lee et al., 2019; Zhang et al., 2024). The gene discussed is TRIB3; the disease is breast cancer.